Neal Masia is Senior Advisor, Healthcare Policy at Guggenheim Partners. CEO of Health Capital Group, LLC and Adjunct Professor of Business and Economics at Columbia University. At Guggenheim, Neal advises many of the world’s largest healthcare investors on global policy developments and policy-driven healthcare innovation. Health Capital Group advises a variety of healthcare companies on business strategy, product development, innovation and leadership. Health Capital Group’s clients include biotechs, medical device companies, data and analytics firms, CROs and healthcare finance companies. Neal spent 18 years at Pfizer Inc, most recently as Chief Economist and a member of Pfizer’s Senior Leadership Council. He built and managed major commercial enterprise platform functions including Global Pricing, Real World Data and Analytics, Global Economics and Market Access/HTA Methods. He also spent nearly 10 years in Finance, where he led Capital markets and Strategy, International Treasury, Pension Investments. Earlier in his Pfizer career Neal held roles in public policy and corporate strategy. Before joining Pfizer, Neal worked as a consultant at the Advisory Board Company, as an economist with the U.S. Congressional Budget Office, in planning and marketing at a venture-backed insurance technology startup, and as a policy advisor to Senator Bill Bradley during his 2000 Presidential campaign. Neal earned a B.A. (High Honors) in Mathematical Economics from Colgate University and Ph.D. in Economics (specializing in Public Finance and Game Theory) from University of Rochester.
Financing Transformative Therapies: Cross-sector perspective on value, payment and real-world evidence
Value based contracting approaches, which need to be informed by real-world evidence, become…